Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

 

CERTIFICATE OF OWNERSHIP AND MERGER

MERGING

INITIO PHARMACEUTICALS, INC.

INTO

CONCURRENT PHARMACEUTICALS, INC.

(PURSUANT TO SECTION 253 OF THE GENERAL

CORPORATION LAW OF DELAWARE)

 

Concurrent Pharmaceuticals, Inc., a Delaware corporation (the “Parent Corporation”), for the purpose of effecting the merger of Initio Pharmaceuticlas, Inc., a Delaware corporation and wholly-owned subsidiary of the Parent Corporation (the “Subsidiary Corporation”), with and into the Parent Corporation, does hereby certify:

 

FIRST: That each of the Parent Corporation and the Subsidiary Corporation is incorporated and duly organized under the laws of the State of Delaware.

 

SECOND: That the Parent Corporation owns one hundred percent (100%) of the outstanding shares of each class of the capital stock of the Subsidiary Corporation.

 

THIRD: That the Parent Corporation hereby merges the Subsidiary Corporation into the Parent Corporation.

 

FOURTH: That attached as Exhibit A hereto is a copy of the resolutions duly adopted by unanimous written consent of the Board of Directors of the Parent Corporation dated December 10, 2001.

 

IN WITNESS WHEREOF, Parent Corporation has caused this certificate to be executed by James B. Tananbaum, President and Chief Executive Officer, this 11th day of December, 2001.

 

 

 

CONCURRENT PHARMACEUTICALS, INC.

a Delaware corporation

 

 

 

 

 

By:

/s/ James B. Tananbaum

 

 

James B. Tannabaurn,

 

 

President and Chief Executive Officer

 

 

STATE OF DELAWARE
SECRETARY OF STATE
DIVISION OF CORPORATIONS
FILED 09:00 AM 12/20/2001
010633974 - 3394459